[Individualized DNA analysis in insurance medicine clarifications].
DNA investigations for the clarification of problems in insurance medicine can be subdivided into 3 groups (1) Traffic accidents (2) identification (3) questionable fraud cases. The development in individualisation by DNA analysis has progressed from the initial restriction fragment length polymorphisms (RFLPs) to the PCR-based polymorphisms. PCR systems are characterised by a very high sensitivity of detection and a high degree of success with highly degraded biological material. The current possibilities for DNA analysis are described and exemplified with special reference to PCR-based polymorphisms.
Brinkmann
B
B
Institut für Rechtsmedizin, Universität Münster.
Wiegand
P
P
D000063:Accidents, Traffic / Q000331:legislation & jurisprudence*; D004247:DNA / Q000235:genetics*; D005607:Fraud / Q000331:legislation & jurisprudence*; D005819:Genetic Markers / Q000235:genetics; D006708:Homicide / Q000331:legislation & jurisprudence; D006801:Humans; D007346:Insurance, Accident / Q000331:legislation & jurisprudence*; D007352:Insurance, Life / Q000331:legislation & jurisprudence*; D010641:Phenotype; D016133:Polymerase Chain Reaction; D012150:Polymorphism, Restriction Fragment Length
D005819:Genetic Markers; D004247:DNA
Individualisierende DNA-Analytik unter versicherungsmedizinischen Fragestellungen.